Fougera Pharmaceuticals Inc.

Belkins
Fougera Pharmaceuticals Inc. is focused on specialty pharmaceuticals in dermatology and is the leading manufacturer of topical pharmaceutical products in the U.S. Over the last 8 years, we have developed over 60 FDA-approved topical therapies in the United States - more than any other company in that time frame. Fougera Pharmaceuticals Inc.'s core divisions are: PharmaDerm - PharmaDerm is a fully vertically-integrated specialty pharmaceutical company dedicated to skin disease with in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. The PharmaDerm division of Fougera Pharmaceuticals Inc. is dedicated to bringing innovative products to dermatologists so they can best care for their patients. Fougera - E. Fougera & Company is Fougera Pharmaceuticals Inc.'s generic drug division, which primarily produces multi-source prescription and OTC dermatologic preparations. Fougera Pharmaceuticals Inc.has been serving the pharmaceutical industry for over 160 years, entering the generic market in 1966. Fougera Pharmaceuticals Inc.'s rich U.S. history of experience and expertise, coupled with its modern technology and innovation, will lead the way for important new generic introductions.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

CHEMICAL REACTIONS DATABASE UPDATES TO IMPROVE R&D INFORMATION EXCHANGE

Drug Target Review | February 26, 2020

news image

The latest file format of the Unified Data Model (UDM) has been released by the Pistoria Alliance, a global, not-for-profit organisation. According to the alliance, this update delivers a stable foundation for the collection and exchange of chemical reaction data and empowers the R&D community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. The alli...

Read More

CHEMICAL TECHNOLOGY

INDAVER AND MONUMENT SIGN MOU WITH DOCKWATER BV

INDAVER, DOCKWATER | June 01, 2021

news image

AVAIO Capital announced that its subsidiary DOCKWATER BV has signed memorandums of understanding with INDAVER NV and MONUMENT CHEMICAL BV. It would provide them with sustainable process water from its DOCKWATER desalination facility in the Port of Antwerp for an 18-year term. DOCKWATER presently has agreements with five companies (Covestro, Evonik, Ashland, INDAVER, and MONUMENT) that have decided to seek a sustainable solution for their water requirements, reducing their expenses...

Read More

JUNCTION CAPITAL PARTNERS COMPLETES ACQUISITION OF WILKINSON CHEMICAL, ANNOUNCES EXPANSION PROJECT

PR Newswire | March 02, 2020

news image

Junction Capital Partners ("JCP") today announced the completion of the acquisition of Wilkinson Chemical, LLC and affiliated entities ("Wilkinson" or the "Company"). The Company will now operate under the name of Wilkinson Solutions. Wilkinson, based in Mayville, Michigan, was founded in 1948 and has been engaged in the production and sale of calcium chloride solution since inception. The Company currently produces 150,000 tons of calcium chloride solut...

Read More

DOW APPROVED US $200+ MILLION EXPANSION OF ALBERTA ETHYLENE PLANT

National Observer | February 02, 2020

news image

U.S. chemical producer Dow Inc. has approved an expansion of its Alberta petrochemical facilities expected to cost between US$200 million and US$225 million. While releasing its fourth-quarter results this week, CEO Jim Fitterling announced the Michigan-based company will increase capacity at its Fort Saskatchewan ethylene plant just north of Edmonton by about 130,000 tonnes per year by adding a process furnace. He says Dow will equally share costs of the expansion and the ethylene output with a...

Read More

Drug Target Review | February 26, 2020

news image

CHEMICAL REACTIONS DATABASE UPDATES TO IMPROVE R&D INFORMATION EXCHANGE

The latest file format of the Unified Data Model (UDM) has been released by the Pistoria Alliance, a global, not-for-profit organisation. According to the alliance, this update delivers a stable foundation for the collection and exchange of chemical reaction data and empowers the R&D community to move forward with its adoption. The release is built upon standard (Allotrope-compatible) vocabularies for units of measure and analytical methods, allowing the systems to be interoperable. The alli...

Read More

CHEMICAL TECHNOLOGY

INDAVER, DOCKWATER | June 01, 2021

news image

INDAVER AND MONUMENT SIGN MOU WITH DOCKWATER BV

AVAIO Capital announced that its subsidiary DOCKWATER BV has signed memorandums of understanding with INDAVER NV and MONUMENT CHEMICAL BV. It would provide them with sustainable process water from its DOCKWATER desalination facility in the Port of Antwerp for an 18-year term. DOCKWATER presently has agreements with five companies (Covestro, Evonik, Ashland, INDAVER, and MONUMENT) that have decided to seek a sustainable solution for their water requirements, reducing their expenses...

Read More

PR Newswire | March 02, 2020

news image

JUNCTION CAPITAL PARTNERS COMPLETES ACQUISITION OF WILKINSON CHEMICAL, ANNOUNCES EXPANSION PROJECT

Junction Capital Partners ("JCP") today announced the completion of the acquisition of Wilkinson Chemical, LLC and affiliated entities ("Wilkinson" or the "Company"). The Company will now operate under the name of Wilkinson Solutions. Wilkinson, based in Mayville, Michigan, was founded in 1948 and has been engaged in the production and sale of calcium chloride solution since inception. The Company currently produces 150,000 tons of calcium chloride solut...

Read More

National Observer | February 02, 2020

news image

DOW APPROVED US $200+ MILLION EXPANSION OF ALBERTA ETHYLENE PLANT

U.S. chemical producer Dow Inc. has approved an expansion of its Alberta petrochemical facilities expected to cost between US$200 million and US$225 million. While releasing its fourth-quarter results this week, CEO Jim Fitterling announced the Michigan-based company will increase capacity at its Fort Saskatchewan ethylene plant just north of Edmonton by about 130,000 tonnes per year by adding a process furnace. He says Dow will equally share costs of the expansion and the ethylene output with a...

Read More